深绿卷柏提取物穗花杉双黄酮抗癌活性研究进展  

Research progress in anti-cancer activity of amentoflavone from Selaginella

作　　者：王秋月 王菊勇[1] 贾方 李雪[1] WANG Qiu-yue;WANG Ju-yong;JIA Fang;LI Xue(Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Shanghai 200032)

机构地区：[1]上海中医药大学附属龙华医院

出　　处：《中南药学》2019年第10期1734-1737,共4页Central South Pharmacy

基　　金：“十三五”科技重大专项-恶性肿瘤等疾病示范性中药新药临床评价技术平台建设子项目（No.2017ZX09304001）

摘　　要：穗花杉双黄酮是深绿卷柏中的主要活性成分之一,具有抗氧化、降血糖、保护血管、抗炎及抗肿瘤等广泛的药理作用。本文重点阐述穗花杉双黄酮抗肿瘤作用机制,为进一步研究开发穗花杉双黄酮提供理论依据。Amentoflavone is one of the main active ingredients in Selaginella. It has many pharmacological activities, such as anti-oxidation, anti-diabetes, blood vessel protection, anti-inflammatory and anti-tumor effects. This paper focused on the anti-tumor mechanism of the amentoflavone, and provided a theoretical basis for further research and development of amentoflavone.

关 键 词：深绿卷柏 穗花杉双黄酮 药理作用 抗肿瘤活性 

分 类 号：R285[医药卫生—中药学]